(Q39328213)

11 September 2017

1 reference

title

Myocarditis: A Clinical Overview (English)

1 reference

11 September 2017

1 reference

A L P Caforio

1

1 reference

11 September 2017

G Malipiero

series ordinal

2

1 reference

11 September 2017

R Marcolongo

series ordinal

3

1 reference

11 September 2017

S Iliceto

series ordinal

4

1 reference

11 September 2017

publication date

1 July 2017

1 reference

Current cardiology reports

11 September 2017

published in

1 reference

11 September 2017

volume

19

1 reference

11 September 2017

issue

7

1 reference

11 September 2017

page(s)

63

1 reference

A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Active versus borderline myocarditis: clinicopathological correlates and prognostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Performance of t1 and t2 mapping cardiovascular magnetic resonance to detect active myocarditis in patients with recent-onset heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

CMR sensitivity varies with clinical presentation and extent of cell necrosis in biopsy-proven acute myocarditis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Delayed gadolinium-enhanced cardiac magnetic resonance in patients with chronic myocarditis presenting with heart failure or recurrent arrhythmias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Cardiac findings during uncomplicated acute influenza in ambulatory adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

The prevalence of myocarditis and skeletal muscle injury during acute viral infection in adults: measurement of cardiac troponins I and T in 152 patients with acute influenza infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Sudden adult death syndrome and other non-ischaemic causes of sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Aggravation of left ventricular dysfunction in patients with biopsy-proven cardiac human herpesvirus A and B infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Parvovirus B19 infection mimicking acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Post-vaccination myositis and myocarditis in a previously healthy male

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Chemical cardiomyopathies: the negative effects of medications and nonprescribed drugs on the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

The Causes of HIV-Associated Cardiomyopathy: A Tale of Two Worlds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Necrotic myocardial cells release damage-associated molecular patterns that provoke fibroblast activation in vitro and trigger myocardial inflammation and fibrosis in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Stress-related cardiomyopathy syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

A Genetically Vulnerable Myocardium May Predispose to Myocarditis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Genetics of susceptibility to viral myocarditis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Myocarditis: infection versus autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Hypereosinophilic syndrome: cardiac diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Cardiac involvement in primary systemic vasculitis and potential drug therapies to reduce cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Myocarditis in Patients With Antisynthetase Syndrome: Prevalence, Presentation, and Outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Lupus Myocarditis: Initial Presentation and Longterm Outcomes in a Multicentric Series of 29 Patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Fulminant Myocarditis with Combination Immune Checkpoint Blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

A review of DRESS-associated myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Fulminant myocarditis and macrophage activation syndrome secondary to adult-onset Still's disease successfully treated with tocilizumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Autoantibodies and cardiovascular dysfunction: cause or consequence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Congenital heart block related to maternal autoantibodies: descriptive analysis of a series of 18 cases from a single center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Diagnosis of myocarditis: death of Dallas criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Diagnosis and treatment of viral myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Echocardiographic findings in asymptomatic systemic lupus erythematosus patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Cardiovascular magnetic resonance in myocarditis: A JACC White Paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Cardiorheumatology: cardiac involvement in systemic rheumatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Endomyocardial biopsy via the femoral access - still safe and valuable diagnostic tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Outcomes and predictors of recovery in acute-onset cardiomyopathy: A single-center experience of patients undergoing endomyocardial biopsy for new heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Giant cell myocarditis. Diagnosis and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Clinically suspected myocarditis with pseudo-infarct presentation: the role of endomyocardial biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Cardiac involvement in Wegener's granulomatosis resistant to induction therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Influence of different aetiologies on clinical course and outcome in patients with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Long-term evolution and prognostic stratification of biopsy-proven active myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Long-term outcome of patients with biopsy-proved myocarditis: comparison with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Predictors of outcome in patients with suspected myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Survival in biopsy-proven myocarditis: a long-term retrospective analysis of the histopathologic, clinical, and hemodynamic predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Prognostic value of the infarct- and non-infarct like patterns and cardiovascular magnetic resonance parameters on long-term outcome of patients after acute myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Predictors of outcome in patients with parvovirus B19 positive endomyocardial biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Venoarterial Extracorporeal Membrane Oxygenation for Acute Fulminant Myocarditis in Adult Patients: A 5-Year Multi-Institutional Experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contrib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Non-rheumatic streptococcal myocarditis - warm hands, warm heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Emerging pharmacologic targets and treatments for myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Predictors at diagnosis of a first Wegener's granulomatosis relapse after obtaining complete remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Successfully Treated Acute Fulminant Myocarditis Induced by Ulcerative Colitis with Extracorporeal Life Support and Infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

A systematic review of intravenous gamma globulin for therapy of acute myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Intravenous immunoglobulin treatment for acute fulminant inflammatory cardiomyopathy: series of six patients and review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Lupus myocarditis: marked improvement in cardiac function after intravenous immunoglobulin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Heart failure not responsive to standard immunosuppressive therapy is successfully treated with high dose intravenous immunoglobulin therapy in a patient with Eosinophilic Granulomatosis with Polyangiitis (EGPA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Treating Life-Threatening Myocarditis by Blocking Interleukin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Long-term outcome of patients with virus-negative chronic myocarditis or inflammatory cardiomyopathy after immunosuppressive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Prompt benefit of early immunosuppressive therapy in acute lymphocytic myocarditis with persistent heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: Potential utility of immunosuppressive therapy in cardiac damage progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-017-0870-X

Anakinra in Fulminant Myocarditis: Targeting Interleukin-1 and the Inflammasome Formation

21 January 2018

1 reference

12 December 2020

Viral myocarditis. A review

1 reference

12 December 2020

ESC working group position paper on myocardial infarction with non-obstructive coronary arteries.

1 reference

12 December 2020

Cardiac troponin T in patients with clinically suspected myocarditis

1 reference

12 December 2020

Echocardiographic findings in fulminant and acute myocarditis

1 reference

12 December 2020

Influenza-related viral myocarditis

1 reference

12 December 2020

Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy

1 reference

12 December 2020

Clinical presentation and diagnosis of myocarditis

1 reference

12 December 2020

Immunohistological diagnosis of myocarditis. Potential role of sarcolemmal induction of the MHC and ICAM-1 in the detection of autoimmune mediated myocyte injury

1 reference

12 December 2020

1 reference

12 December 2020

Acute biopsy-proven lymphocytic myocarditis mimicking Takotsubo cardiomyopathy

1 reference

12 December 2020

An atypical complication of atypical pneumonia

1 reference

12 December 2020

Myocarditis in a young man with adult onset Still's disease successfully treated with Il-1 blocker

1 reference

12 December 2020

Endomyocardial biopsy should be performed in every patient with suspected myocarditis

1 reference

12 December 2020

Myocarditis. A histopathologic definition and classification

1 reference

12 December 2020

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of [...]

1 reference

12 December 2020

The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology

1 reference

12 December 2020

Rituximab in recurrent idiopathic giant cell myocarditis after heart transplantation: a potential therapeutic approach

1 reference

12 December 2020

Cardiovascular magnetic resonance imaging pattern at the time of diagnosis of treatment naïve patients with connective tissue diseases

1 reference

12 December 2020

Multimodality Assessment of Cardiac Involvement in Churg-Strauss Syndrome Patients in Clinical Remission

1 reference

12 December 2020

Human parvovirus B19-associated myocarditis

1 reference

12 December 2020

Alemtuzumab as a novel treatment for refractory giant cell myocarditis after heart transplantation

1 reference

12 December 2020

Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery

1 reference

12 December 2020

Circulating cardiac-specific autoantibodies as markers of autoimmunity in clinical and biopsy-proven myocarditis. The Myocarditis Treatment Trial Investigators

1 reference

12 December 2020

Silent myocarditis in myasthenia gravis. Role of cardiovascular magnetic resonance imaging

1 reference

12 December 2020

Diagnostic synergy of non-invasive cardiovascular magnetic resonance and invasive endomyocardial biopsy in troponin-positive patients without coronary artery disease

1 reference

12 December 2020

Giant cell myocarditis, in a patient with Crohn's disease, treated with etanercept--a tumour necrosis factor-alpha antagonist

1 reference

12 December 2020

10.1007/S11886-017-0870-X

Identifiers

DOI

1 reference

11 September 2017

1 reference